Shares of Amgen Inc. AMGN inched 0.19% higher to $264.49 Tuesday, on what proved to be an all-around positive trading session ...

Amgen's leukemia drug Blincyto infringes patents owned by Germany's Lindis Biotech, a Delaware federal jury said in a verdict ...

Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently ...

We gleaned this information from our observations today when Benzinga's options scanner highlighted 10 extraordinary options ...

The Amgen Scholars Program (ASP) is an international program funded by the Amgen Foundation with the direction of Harvard ...

StockNews.com lowered shares of Amgen (NASDAQ:AMGN – Free Report) from a strong-buy rating to a buy rating in a research ...

Amgen Inc (AMGN) stock saw a modest uptick, ending the day at $263.38 which represents a slight increase of $2.19 or 0.84% from the prior close of $261.19. The stock opened at $269 and touched a low ...

Novo Nordisk's CagriSema shows 22.7% weight loss in Phase 3 trials, while tolerability concerns grow. MariTide offers ...

We recently compiled a list of the 10 Dogs of the Dow Dividend Stocks to Invest in. In this article, we are going to take a ...

Novo Nordisk stock crashed Friday after the firm's next-generation weight-loss drug missed expectations in a highly ...

We recently published a list of 10 Best Safe Stocks To Buy According to Analysts. In this article, we are going to take a ...